LASE Innovation Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
LASE Innovation Inc. - overview
Established
2018
Location
Waltham, MA, US
Primary Industry
Medical Devices & Equipment
About
LASE Innovation Inc. specializes in advanced life-science tools, focusing on high-dimensional single-cell analysis through its innovative LP Cell Barcoding™ platform, enhancing the research capabilities in the life sciences sector. Founded in 2018, LASE Innovation Inc. operates from Waltham, US.
The company focuses on high-dimensional single-cell analysis and has not undergone any noted pivots. Sheldon Kwok serves as both the founder and CEO. In July 2020, LASE Innovation raised KRW 6 billion in a Series A funding round led by Otium Capital, with Kakao Ventures participating. This funding round constitutes the total amount raised by the company so far, which is KRW 6 billion.
LASE Innovation's primary offering is the LP Cell Barcoding™ platform, which employs novel laser particle technology for high-dimensional single-cell analysis. This system allows researchers to identify and track individual cells across platforms such as flow cytometry, imaging, and sequencing. It serves clients in the life sciences sector, including academic institutions and pharmaceutical companies across North America, Europe, and Asia. The company's revenue is generated from the sale of the LP Cell Barcoding™ platform and related single-cell analysis services.
LASE Innovation operates on a business-to-business model, engaging with research institutions and pharmaceutical firms through customized service agreements that may involve multi-year contracts or subscription models. Revenue is obtained through initial setup fees, training, and ongoing usage of the technology, structured to meet client needs with tiered pricing based on the service volume required. Following its Series A funding round in July 2020, LASE Innovation plans to enhance its product offerings and expand into new markets. The funds raised will support the development of upcoming products designed for broader applications in single-cell analysis.
The company is targeting expansion into new geographic regions, though specific timelines for these initiatives have not been disclosed.
Current Investors
Kakao Ventures, Otium Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Healthcare IT, Medical Devices & Equipment
Website
www.laseinnovation.com
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
LASE Innovation Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.